Literature DB >> 6288808

Potentiation of neutralization of Varicella-Zoster virus to antibody to immunoglobulin.

Y Asano, P Albrecht, S Stagno, M Takahashi.   

Abstract

Antibody to varicella-zoster virus was measured in Vero cell cultures by a conventional and an enhanced plaque neutralization test. In the latter, heterologous antibody to human immunoglobulin was added to the virus-serum mixture to potentiate the neutralization reaction. The antibody to human immunoglobulin enhanced the sensitivity of the neutralization test seven- to 107-fold as compared with the conventional procedure. The test was highly reproducible in that individual serum titers fluctuated in a twofold range on repeated testing. A prozone phenomenon was observed in the enhanced neutralization test in low-titered sera, but not with high-titered sera or with specimens of cerebrospinal fluid. The specificity of the test was confirmed by the detection of seroconversion in recipients of live varicella virus vaccine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288808     DOI: 10.1093/infdis/146.4.524

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

1.  Evaluation of humoral immunity to varicella-zoster virus by an enhanced neutralization test and by the fluorescent antibody to membrane antigen test.

Authors:  Y Asano; P Albrecht; L K Vujcic; G V Quinnan; M Takahashi
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

Review 2.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

Review 3.  The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19.

Authors:  Arturo Casadevall; Liise-Anne Pirofski; Michael J Joyner
Journal:  mBio       Date:  2021-03-02       Impact factor: 7.867

4.  Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2.

Authors:  Wael Bahnan; Sebastian Wrighton; Martin Sundwall; Anna Bläckberg; Olivia Larsson; Urban Höglund; Hamed Khakzad; Magdalena Godzwon; Maria Walle; Elisabeth Elder; Anna Söderlund Strand; Lotta Happonen; Oscar André; Johannes Kumra Ahnlide; Thomas Hellmark; Vidar Wendel-Hansen; Robert Pa Wallin; Johan Malmstöm; Lars Malmström; Mats Ohlin; Magnus Rasmussen; Pontus Nordenfelt
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.